Mark Chen
@MarkChenMDPhD
Followers
360
Following
1K
Media
26
Statuses
235
PGY-5 @DukeRadOnc, Holman/RORS | Protein engineering, RPT, condensates | Views my own 🇺🇲
USA
Joined November 2017
RT @DukeRadOnc: Welcome to our exceptional new resident classes! We're thrilled to have you here at Duke #RadOnc 💙 @DukeCancer @DukeMedScho….
0
4
0
RT @ASTRO_org: 📣 Calling all graduating residents! Don’t forget to become an Authorized User. Check out this recently recorded webinar host….
0
5
0
RT @HenningWillers: 1/2 . It is not too early to start thinking about the #RadRes2025 Meeting in beautiful #PuertoRico Sept 21-24, 2025 🌞🌴🍹….
0
14
0
Congrats Pete! @pghendrickson.
Congrats to Pete Hendrickson, MD, PhD, one of five faculty from the @DukeMedSchool to receive a 2025 Physician-Scientist Strong Start award; the award will support his research on a sarcoma subtype driven by a novel gene fusion called CIC::DUX4 sarcoma 🔗
0
0
3
RT @aventura71: 1/ 🚨New paper on ecDNAs from our lab! . We reveal a strategy to engineer extrachromosomal DNA (ecDNA) amplifications in cel….
0
91
0
RT @NiuSanford: Our comprehensive assessment of NCI cooperative group trials is out in @JNCI_Now! . If you are involved or enrolling in coo….
0
60
0
RT @DKirschMDPhD: Just in time for #CTOS2024: Thrilled to share SU2C-SARC032 (NCT03092323), a randomized trial of pembrolizumab in Stage 3….
0
54
0
RT @NC_Renic: Academia isn’t about fame, or money, or approval. It’s about downloading as many pdfs as you can before you die.
0
8K
0
RT @DukeRadOnc: Calling all #MedStudents interested in #RadOnc: Meet us at #ASTRO24! Chat with our @DukeCancer residents and PD at a meet a….
0
4
0
RT @DukeRadOnc: Match update: We're encouraging #PhysicianScientist applications for #Match2025 through a #RadOnc Research Scholar Track po….
0
6
0
RT @DukeRadOnc: We're excited to offer regionally coordinated in-person residency interviews this year! To minimize financial impact, @Duke….
0
6
0
Top takeaways for me: 1) developing radiopharmaceuticals for LMD/BM; 2) new biology, SLYM; 3) broadening the scope of LMD/BM work to collaborate with larger research areas, e.g. stroke, neurodegenerative diseases; 4) first steps for industry collabs (use network and MSLs). 2/2.
0
0
4
Learned a ton at #SNOASCO24 about LMD/brain mets. also great to share our genomics work from @DukeRadOnc. It truly takes a village, thanks @HTawbi_MD Priya Kumthekar @DHaasKogan for bringing together patients, industry, and everyone working in this important space! 1/2.
Reflecting on last 48 hours of #snoasco24 whirlwind of excellent talks from invited speakers & original unpublished research, largest CNS Mets Meeting with 300 participants, >170 abstracts submitted, & 2 visionary keynote speakers Profs. Reinhard Dummer & Melanie Hayden Gephart
2
1
12
RT @nlinmd: Deep dive into the practicalities and barriers to bringing innovations to pts with brain mets and LMD at the 2024 SNO/ASCO CNS….
0
7
0
RT @DukeMets: Jamil Qazi of @DukeRadOnc presenting on our retrospective study of the impact of systemic therapy after SRS in patients with….
0
4
0